On July 28, 2025, China SXT Pharmaceuticals, Inc. held a shareholder meeting where a new class of shares was approved, establishing Class B shares with 50 votes each; 39,648,847 out of 116,027,758 shares voted, surpassing the quorum required, with 39,642,273 votes in favor.